Levy Richard S
Insider transactions at 5 companies
This page shows all SEC Form 4 filings attributed to Levy Richard S. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| MDGL | Option Exercise | 6,000 | $16.46 | $98,760 | Nov 13, 2025 | |
| KNSA | Option Exercise | 1,101 | — | — | Jul 1, 2025 | |
| MDGL | Award / Grant | 715 | — | — | Jun 20, 2025 | |
| KNSA | Option Exercise | 3,173 | — | — | Jun 5, 2025 | |
| TARA | Purchase | 20,000 | $3.19 | $63,800 | May 14, 2025 | |
| TARA | Purchase | 20,000 | $3.19 | $63,800 | May 14, 2025 | |
| MDGL | Option Exercise | 9,470 | $65.06 | $616,118 | Apr 10, 2025 | |
| KNSA | Option Exercise | 1,303 | — | — | Nov 7, 2024 | |
| MDGL | Sale | 5,000 | $350.00 | $1,750,000 | Nov 7, 2024 | |
| MDGL | Sale | 300 | $304.29 | $91,287 | Nov 1, 2024 | |
| MDGL | Award / Grant | 714 | — | — | Jun 25, 2024 | |
| KNSA | Option Exercise | 4,373 | — | — | Jun 6, 2024 | |
| KNSA | Option Exercise | 747 | — | — | May 3, 2024 | |
| MDGL | Sale | 300 | $267.07 | $80,121 | Apr 1, 2024 | |
| KNSA | Option Exercise | 2,777 | — | — | Nov 3, 2023 | |
| KNSA | Option Exercise | 5,000 | — | — | Jun 29, 2023 | |
| MDGL | Award / Grant | 1,198 | — | — | Jun 15, 2023 | |
| MDGL | Option Exercise | 12,489 | $105.08 | $1,312,344 | Jan 17, 2023 | |
| KOD | Purchase | 250 | $43.37 | $10,843 | Mar 20, 2020 | |
| TARA | Award / Grant | 31,000 | — | — | Jan 10, 2020 | |
| MDGL | Purchase | 7 | $16.25 | $114 | Aug 23, 2017 | |
| MDGL | Purchase | 127 | $16.14 | $2,050 | Aug 22, 2017 | |
| MDGL | Purchase | 200 | $16.02 | $3,204 | Aug 21, 2017 | |
| INCY | EVP, Chief Drug Dev Officer | Option Exercise | 3,937 | $18.32 | $72,126 | Jan 6, 2016 |
| INCY | EVP, Chief Drug Dev Officer | Option Exercise | 3,937 | $18.32 | $72,126 | Dec 7, 2015 |
| INCY | EVP, Chief Drug Dev Officer | Sale | 3,936 | $116.51 | $458,583 | Nov 6, 2015 |
| INCY | EVP, Chief Drug Dev Officer | Sale | 3,937 | $122.29 | $481,456 | Oct 6, 2015 |
| INCY | EVP, Chief Drug Dev Officer | Sale | 4,301 | $130.00 | $559,130 | Sep 11, 2015 |
| INCY | EVP, Chief Drug Dev Officer | Sale | 3,937 | $118.90 | $468,109 | Sep 8, 2015 |
| INCY | EVP, Chief Drug Dev Officer | Sale | 3,936 | $111.95 | $440,635 | Aug 6, 2015 |
| INCY | EVP, Chief Drug Dev Officer | Sale | 70,217 | $120.00 | $8,426,040 | Jul 15, 2015 |
| INCY | EVP, Chief Drug Dev Officer | Sale | 3,937 | $107.00 | $421,259 | Jul 6, 2015 |
| INCY | EVP, Chief Drug Dev Officer | Sale | 20,000 | $108.13 | $2,162,600 | Jun 19, 2015 |
| INCY | EVP, Chief Drug Dev Officer | Option Exercise | 3,937 | $18.32 | $72,126 | Jun 8, 2015 |
| INCY | EVP, Chief Drug Dev Officer | Option Exercise | 7,412 | $18.32 | $135,788 | May 6, 2015 |
| INCY | EVP, Chief Drug Dev Officer | Sale | 25,000 | $88.77 | $2,219,250 | Apr 6, 2015 |
| INCY | EVP, Chief Drug Dev Officer | Sale | 25,000 | $89.91 | $2,247,750 | Mar 6, 2015 |
| INCY | EVP, Chief Drug Dev&Medical Of | Sale | 12,000 | $76.90 | $922,800 | Feb 17, 2015 |
| INCY | EVP, Chief Drug Dev&Medical Of | Sale | 25,000 | $75.11 | $1,877,750 | Feb 6, 2015 |
| INCY | EVP, Chief Drug Dev&Medical Of | Sale | 12,000 | $73.07 | $876,840 | Jan 16, 2015 |
| INCY | EVP, Chief Drug Dev&Medical Of | Award / Grant | 3,022 | — | — | Jan 8, 2015 |
| INCY | EVP, Chief Drug Dev&Medical Of | Option Exercise | 25,000 | $18.32 | $458,000 | Jan 6, 2015 |
| INCY | EVP, Chief Drug Dev&Medical Of | Option Exercise | 12,000 | $14.72 | $176,640 | Dec 16, 2014 |
| INCY | EVP, Chief Drug Dev&Medical Of | Option Exercise | 12,000 | $14.72 | $176,640 | Nov 17, 2014 |
| INCY | EVP, Chief Drug Dev&Medical Of | Option Exercise | 13,904 | $3.11 | $43,241 | Oct 23, 2014 |
| INCY | EVP, Chief Drug Dev&Medical Of | Sale | 8,000 | $49.03 | $392,240 | Oct 16, 2014 |
| INCY | EVP, Chief Drug Dev&Medical Of | Option Exercise | 8,000 | $14.72 | $117,760 | Sep 16, 2014 |
| INCY | EVP, Chief Drug Dev&Medical Of | Sale | 8,000 | $51.97 | $415,760 | Aug 18, 2014 |
| INCY | EVP, Chief Drug Dev&Medical Of | Option Exercise | 8,000 | $14.72 | $117,760 | Jul 16, 2014 |
| INCY | EVP, Chief Drug Dev&Medical Of | Option Exercise | 8,000 | $14.72 | $117,760 | Jun 16, 2014 |